Inhibition of the lectin pathway of complement ameliorates hypocomplementemia and restores serum bactericidal activity in patients with severe COVID-19
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Clinical and translational medicine - 12(2022), 7 vom: 27. Juli, Seite e980 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lynch, Nicholas J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9007-36-7 |
|---|
| Anmerkungen: |
Date Completed 19.07.2022 Date Revised 22.03.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1002/ctm2.980 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34359563X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34359563X | ||
| 003 | DE-627 | ||
| 005 | 20231226020821.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ctm2.980 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1145.xml |
| 035 | |a (DE-627)NLM34359563X | ||
| 035 | |a (NLM)35839316 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lynch, Nicholas J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Inhibition of the lectin pathway of complement ameliorates hypocomplementemia and restores serum bactericidal activity in patients with severe COVID-19 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.07.2022 | ||
| 500 | |a Date Revised 22.03.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Complement C4 |2 NLM | |
| 650 | 7 | |a Lectins |2 NLM | |
| 650 | 7 | |a Complement System Proteins |2 NLM | |
| 650 | 7 | |a 9007-36-7 |2 NLM | |
| 700 | 1 | |a Chan, Andrew C Y |e verfasserin |4 aut | |
| 700 | 1 | |a Ali, Youssif M |e verfasserin |4 aut | |
| 700 | 1 | |a Khatri, Priyanka |e verfasserin |4 aut | |
| 700 | 1 | |a Bamigbola, Ifeoluwa E |e verfasserin |4 aut | |
| 700 | 1 | |a Demopulos, Gregory |e verfasserin |4 aut | |
| 700 | 1 | |a Paganessi, Muriel |e verfasserin |4 aut | |
| 700 | 1 | |a Rambaldi, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Schwaeble, Wilhelm J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and translational medicine |d 2012 |g 12(2022), 7 vom: 27. Juli, Seite e980 |w (DE-627)NLM224642685 |x 2001-1326 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2022 |g number:7 |g day:27 |g month:07 |g pages:e980 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ctm2.980 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2022 |e 7 |b 27 |c 07 |h e980 | ||